Growth Metrics

Rockwell Medical (RMTI) Return on Equity (2016 - 2025)

Historic Return on Equity for Rockwell Medical (RMTI) over the last 15 years, with Q3 2025 value amounting to 0.17%.

  • Rockwell Medical's Return on Equity fell 1200.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.02% for FY2024, which is 4700.0% up from last year.
  • As of Q3 2025, Rockwell Medical's Return on Equity stood at 0.17%, which was down 1200.0% from 0.07% recorded in Q2 2025.
  • Rockwell Medical's Return on Equity's 5-year high stood at 28.25% during Q1 2022, with a 5-year trough of 4.79% in Q4 2021.
  • Moreover, its 5-year median value for Return on Equity was 0.61% (2023), whereas its average is 0.44%.
  • As far as peak fluctuations go, Rockwell Medical's Return on Equity skyrocketed by 292300bps in 2022, and later plummeted by -292400bps in 2023.
  • Rockwell Medical's Return on Equity (Quarter) stood at 4.79% in 2021, then soared by 74bps to 1.24% in 2022, then surged by 67bps to 0.41% in 2023, then surged by 96bps to 0.02% in 2024, then crashed by -845bps to 0.17% in 2025.
  • Its last three reported values are 0.17% in Q3 2025, 0.07% for Q2 2025, and 0.01% during Q1 2025.